| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Regular Articles |






From the Department of Biomedical Sciences and
Oncology,*
University of Turin, Turin, Italy; the Division
of Cell and Molecular Pathology
and the
Department of Pathology,
University of
Zürich, Zürich, Switzerland; and the Department of
Pathology and Laboratory Medicine,§
Mayo Clinic
and Foundation, Rochester, Minnesota
Mixed medullary-follicular carcinomas (MMFCs) are tumors of the thyroid that display morphological and immunohistochemical features of both medullary and follicular neoplasms. The histogenetic origin and possible molecular mechanisms leading to MMFCs are still unclear. To address these questions, we have isolated the two histological components of 12 MMFCs by (laser-based) microdissection, analyzed them for mutations in the RET proto-oncogene and allelic losses of nine loci on six chromosomes, and studied the clonal composition of MMFCs in female patients. Our results provide strong evidence that the follicular and medullary components in MMFCs are not derived from a single progenitor cell, because the seven tumors amenable for analysis consistently exhibited a different pattern of mutations, allelic losses, and clonal composition. We also demonstrate that follicular structures in MMFCs are often oligo/polyclonal and more frequently exhibit hyperplastic than neoplastic histological features, indicating that at least a subset of MMFCs are composed of a medullary thyroid carcinoma containing hyperplastic follicles.
This article has been cited by other articles:
![]() |
E. Saggiorato, I. Rapa, F. Garino, G. Bussolati, F. Orlandi, M. Papotti, and M. Volante Absence of RET Gene Point Mutations in Sporadic Thyroid C-Cell Hyperplasia J. Mol. Diagn., April 1, 2007; 9(2): 214 - 219. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Ling, A. Persson, B. Berne, M. Uhlen, J. Lundeberg, and F. Ponten Persistent p53 Mutations in Single Cells from Normal Human Skin Am. J. Pathol., October 1, 2001; 159(4): 1247 - 1253. [Abstract] [Full Text] |
||||
![]() |
E. J. M. Speel, A. F. Scheidweiler, J. Zhao, C. Matter, P. Saremaslani, J. Roth, P. U. Heitz, and P. Komminoth Genetic Evidence for Early Divergence of Small Functioning and Nonfunctioning Endocrine Pancreatic Tumors: Gain of 9Q34 Is an Early Event in Insulinomas Cancer Res., July 1, 2001; 61(13): 5186 - 5192. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Barghorn, E. J. M. Speel, B. Farspour, P. Saremaslani, S. Schmid, A. Perren, J. Roth, P. U. Heitz, and P. Komminoth Putative Tumor Suppressor Loci at 6q22 and 6q23-q24 Are Involved in the Malignant Progression of Sporadic Endocrine Pancreatic Tumors Am. J. Pathol., June 1, 2001; 158(6): 1903 - 1911. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Bunone, M. Uggeri, P. Mondellini, M. A. Pierotti, and I. Bongarzone RET Receptor Expression in Thyroid Follicular Epithelial Cell-derived Tumors Cancer Res., June 1, 2000; 60(11): 2845 - 2849. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Matias-Guiu Mixed Medullary and Follicular Carcinoma of the Thyroid : On the Search for Its Histogenesis Am. J. Pathol., November 1, 1999; 155(5): 1413 - 1418. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |